Oral THC Modified Some Oral Morphine Outcomes in Mice but Left Withdrawal Diarrhea Unchanged

Oral THC coadministration reduced several morphine-related outcomes in mice, but the benefits were not uniform. Withdrawal jumping decreased while diarrhea remained unchanged, and a very high morphine challenge limited the apparent prevention of antinociceptive tolerance.

The regimen used oral administration

ICR mice received repeated high-dose oral morphine, with some groups also receiving an oral THC dose that was not antinociceptive by itself in the protocol. Morphine tolerance was prevented under several challenge conditions, but not when a very high morphine dose was used. The term low dose in this animal study should not be treated as a human dosing recommendation.

Withdrawal outcomes split apart

Chronic THC coadministration reduced naloxone-precipitated platform jumping but did not reduce diarrhea. Acute THC in morphine-tolerant mice produced a similar distinction. Consequently, a statement that THC eliminated opioid withdrawal would be inconsistent with the measured outcomes.

Cross-tolerance was not observed in the separate test

Morphine-tolerant mice were not cross-tolerant to acute THC antinociception; they were more sensitive in that comparison. This result concerns the direction from prior morphine to later THC and should remain separate from the chronic cotreatment findings.

The study offers an experimental oral-route comparison and preserves an important negative finding. Its suggestion of possible clinical benefit was prospective. It does not establish effective treatment of opioid tolerance or withdrawal in people, and the different challenge results argue against treating the combination as universally protective.

Related: interpreting cannabis tolerance claims.

Research cited

Cichewicz DL; Welch SP. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol. The Journal of pharmacology and experimental therapeutics (2003). doi:10.1124/jpet.102.046870. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Rat THC–Alcohol Study Found Cross-Tolerance Without Faster Drug Disappearance

A 1979 female-rat study found THC-to-alcohol cross-tolerance on a coordination task without evidence that faster drug disappearance explained the result. The reverse direction was incomplete, so the two exposure histories were not equivalent. The challenge doses were matched by behavioral effect Acute THC and ethanol challenges were selected to reduce…

Spread the love

Read Article: A Rat THC–Alcohol Study Found Cross-Tolerance Without Faster Drug Disappearance

Behavioral THC Tolerance Did Not Eliminate Antibody-Response Suppression in Rats

A 1980 rat study reported behavioral tolerance during oral THC treatment without tolerance to suppression of selected antibody-related responses. The timing of THC relative to antigen exposure also changed the immune result. The immune challenge was experimentally defined Rats received oral THC or vehicle around an antigenic challenge with sheep…

Spread the love

Read Article: Behavioral THC Tolerance Did Not Eliminate Antibody-Response Suppression in Rats

Matched Food-Delivery Schedules Still Produced Different THC Adaptation Patterns in Monkeys

A 1980 squirrel-monkey experiment matched baseline food-delivery patterns yet found schedule-dependent adaptation to THC. The findings offered only partial support for the idea that reinforcement loss alone explains behavioral tolerance. Two response rules produced comparable baseline rewards One component required a long interval between responses, while another used a modified…

Spread the love

Read Article: Matched Food-Delivery Schedules Still Produced Different THC Adaptation Patterns in Monkeys

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us